Mika Komori
Kobe, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Patient-Doctor Communication in Migraine: Results from the OVERCOME (Japan) 2nd Study.
Journal: Neurology and therapy
Published: June 26, 2025
Real-world use of over-the-counter medications by patients with migraine in Japan: results from the OVERCOME (Japan) 2nd study.
Journal: The journal of headache and pain
Published: December 18, 2024
The dual impact of ictal and interictal burden in migraine: an analysis from the ObserVational survey of the Epidemiology, tReatment, and Care Of MigrainE (OVERCOME) Japan second study.
Journal: The journal of headache and pain
Published: December 13, 2024
The Impact of Migraine on the Whole Life Course of Patients: Results from the OVERCOME (Japan) 2nd Study.
Journal: Neurology and therapy
Published: October 10, 2024
The perception gap on migraine: a survey study of the migraine patients, family members, and physicians
Journal: Rinsho shinkeigaku = Clinical neurology
Published: June 23, 2024
Long-term treatment with lasmiditan in patients with migraine: post hoc analysis of treatment patterns and outcomes from the open-label extension of the CENTURION randomized trial.
Journal: The journal of headache and pain
Published: December 19, 2023
Clinical Evaluation After Discontinuation of Galcanezumab in Japanese Patients with Episodic and Chronic Migraine: Analysis of a Randomized, Placebo-Controlled Trial and Open-label Extension Study.
Journal: Neurology and therapy
Published: November 29, 2023
Impact of migraine on family members: an investigation by Impact of Migraine on Partners and Adolescent Children (IMPAC)
Journal: Rinsho shinkeigaku = Clinical neurology
Published: November 21, 2023
Impact of Migraine on Daily Life: Results of the Observational survey of the Epidemiology, Treatment, and Care of Migraine (OVERCOME [Japan]) Study.
Journal: Neurology and therapy
Published: August 15, 2023
Galcanezumab Efficacy Through the Dosing Interval in Japanese Patients with Episodic Migraine: Post Hoc Analysis of a Phase 2 Randomized Trial.
Journal: Neurology and therapy
Published: June 19, 2023
Outcomes and Factors Associated with Insufficient Effectiveness of Acute Treatments of Migraine in Japan: Results of the ObserVational survey of the Epidemiology, tReatment, and Care Of MigrainE (OVERCOME [Japan]) Study.
Journal: Drugs - real world outcomes
Published: April 12, 2023
Last Updated: 09/26/2026